Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Dodgers rumors: LA among multiple suitors for ex-Yankees star reliever

The Los Angeles Dodgers’ most discussed storyline this offseason is their pursuit of a reunion with Tarik Skubal . The Dodgers are also seeking bullpen help, however, especially with Evan Phillips recently signing with the Atlanta Braves . According to Jesse Rogers of ESPN, LA is among five known suitors for former New York Yankees and Arizona […] The post Dodgers rumors: LA among multiple…

Dodgers rumors: LA among multiple suitors for ex-Yankees star reliever

The Los Angeles Dodgers are among several teams interested in signing Jonathan Loaisiga, a former New York Yankees and Arizona Diamondbacks reliever. ESPN's Jesse Rogers reported that the Dodgers are one of five teams pursuing Loaisiga, who posted a 2.42 ERA in 67 games for the Diamondbacks last season. Loaisiga, 32, previously pitched for the Yankees from 2018 to 2025 before spending 2026 with the Diamondbacks.

Despite his inconsistent performance with the Yankees, Loaisiga has shown promise in the past, including a 2.17 ERA over 57 outings in 2021. The Dodgers are expected to face competition from other teams, including the Yankees, in their pursuit of the reliever. Loaisiga's experience with the National League West, specifically with the Diamondbacks, could be of advantage to the Dodgers.

However, the Yankees and other potential suitors should not be discounted as Loaisiga's free agency progresses.

Written by urgent.news from Yahoo Sports's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at sports.yahoo.com →

More in Finance & Markets

5 Dividend Stocks With High Yields That Are Safer Than You Might Think

A high yield is a sign that investors are worried about a business, but sometimes that concern is overwrought.

  • Pfizer's 5.9% yield is supported by an 85% payout ratio, indicating sustainability.
  • Bristol Myers Squibb's 4% yield has a 55% payout ratio, considered reasonable for pharmaceuticals.
  • Hormel Foods' 5.3% yield is backed by a low debt-to-equity ratio and strong dividend growth history.

More from Saturday 14 November →